Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH)

Market Open
16 Oct, 02:52 PM
NYSE NYSE
$
94. 86
+0.48
+0.5033%
$
18B Market Cap
24.97 P/E Ratio
0.96% Div Yield
24,230 Volume
8.06 Eps
$ 94.38
Previous Close
Add Transaction
Day Range
94.72 95.98
Year Range
79.12 106.88
Want to track ZBH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Should Value Investors Buy Zimmer Biomet (ZBH) Stock?

Should Value Investors Buy Zimmer Biomet (ZBH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 4 days ago
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?

Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 week ago
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 4 weeks ago
Zimmer Biomet - Showing Signs Of Life

Zimmer Biomet - Showing Signs Of Life

Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transformation factors, R&D and M&A efforts. Earnings growth is lagging sales, but this hopefully should catch up soon.

Seekingalpha | 1 month ago
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term

Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 month ago
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?

Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?

ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, though debt and competition remain concerns.

Zacks | 1 month ago
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock

Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 months ago
Zimmer Biomet Q2 Earnings Call Highlights

Zimmer Biomet Q2 Earnings Call Highlights

Zimmer Biomet NYSE: ZBH reported second-quarter 2026 net sales of $2.177 billion, up 4.8% on a reported basis and 4.0% on an organic constant-currency basis, as growth in hips, specialty businesses and technology helped offset weaker performance in certain other product lines.

Marketbeat | 2 months ago
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 months ago
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript

Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript

Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
ZBH's Q2 Earnings Beat, '26 View Raised, Stock Up in Pre-Market

ZBH's Q2 Earnings Beat, '26 View Raised, Stock Up in Pre-Market

ZBH beats second-quarter earnings and revenue estimates, raises its 2026 outlook and gains in pre-market despite pressure on adjusted margins.

Zacks | 2 months ago
Zimmer (ZBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zimmer (ZBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 2 months ago
Loading...
Load More